MENU
SNGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Soligenix (SNGX) Earnings Date & Reports
Soligenix Inc is a late-stage biopharmaceutical company based in the United States... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
SNGX is expected to report earnings to -11 cents per share on November 06
Q3'26
Est.
$-0.12
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.18
Q4'25
Missed
by $0.17
Q3'25
Missed
by $0.46
The last earnings report on August 07 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 95.62K shares outstanding, the current market capitalization sits at 7.91M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
What is the Short Interest Ratio?
Can You Sell a Bond for Less Than the Price You Paid For It?
What Are the Dynamics and Implications of the Black Market?
AI Robots: Top 7 Trend Traders, Signals Only, on September 24, 2024
WW International’s Meteoric +3568.14% Surge in 2025: Drivers, Risks, and Future Outlook
A.I. Advisor
published General Information
General Information
a manufacturer of biodefense vaccines and oral therapeutic products
Industry Biotechnology
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
14
Web
https://www.soligenix.com